Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CP✓SelectedUSD · CPGSK vs CP performance historyLatest closeAs of-2.71%09/08
Stock and ETF performance explorer

GSK vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+76.8%
CP return
+219.6%
Excess return
-142.8%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D-2.7%-0.5%-2.2%-2.6%
7D-4.2%+2.4%-6.6%-4.9%
30D-7.5%-0.5%-7.0%-7.4%
3M-3.3%+1.4%-4.7%-3.8%
6M-9.3%+10.3%-19.6%-12.0%
YTD+1.6%+24.3%-22.7%-4.8%
1Y+25.5%+20.4%+5.0%+18.4%
3Y+49.3%+21.8%+27.5%+38.7%
5Y+46.7%+31.5%+15.1%+30.7%
10Y+76.8%+223.2%-146.4%+18.9%
All+76.8%+219.6%-142.8%+18.9%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling